1. Adelaide Research & Scholarship

Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 51-60 of 253 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Correlation of antiangiogenic, antioxidant and cytotoxic activities of some Sudanese medicinal plants with phenolic and flavonoid contentsHassan, L.; Khadeer Ahamed, M.; Abdul Majid, A.; Baharetha, H.; Muslim, N.; Nassar, Z.; Abdul Majid, A.
2016Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depressionLoo, C.; Gálvez, V.; O'Keefe, E.; Mitchell, P.; Hadzi-Pavlovic, D.; Leyden, J.; Harper, S.; Somogyi, A.; Lai, R.; Weickert, C.; Glue, P.
2016Diversion and injection of buprenorphine-naloxone film two years post-introduction in AustraliaLarance, B.; Mattick, R.; Ali, R.; Lintzeris, N.; Jenkinson, R.; White, N.; Kihas, I.; Cassidy, R.; Degenhardt, L.; Wilkinson, C.; Livingston, M.
2014Antiangiogenic effect of Ficus deltoidea jack standardised leaf extractsShafaei, A.; Syima Muslim, N.; Nassar, Z.; Aisha, A.; Abdul Majid, A.; Ismail, Z.
2015Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulationPeacock, A.; Degenhardt, L.; Hordern, A.; Larance, B.; Cama, E.; White, N.; Kihas, I.; Bruno, R.
2017Functionalized Graphene Oxide with Chitosan for Protein Nanocarriers to Protect against Enzymatic Cleavage and Retain Collagenase ActivityEmadi, F.; Amini, A.; Gholami, A.; Ghasemi, Y.
2015Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocolDegenhardt, L.; Larance, B.; Bruno, R.; Lintzeris, N.; Ali, R.; Farrell, M.
2015A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodonePeacock, A.; Degenhardt, L.; Larance, B.; Cama, E.; Lintzeris, N.; Ali, R.; Bruno, R.
2014A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumorsChiorean, E.; Sweeney, C.; Youssoufian, H.; Qin, A.; Dontabhaktuni, A.; Loizos, N.; Nippgen, J.; Amato, R.
2015A comparison of patterns of spontaneous adverse drug reaction reporting with St. John's Wort and fluoxetine during the period 2000-2013Hoban, C.; Byard, R.; Musgrave, I.

Discover